Tau and Axonal Transport Misregulation in Tauopathies. 2019

Benjamin Combs, and Rebecca L Mueller, and Gerardo Morfini, and Scott T Brady, and Nicholas M Kanaan
Department of Translational Neuroscience, College of Human Medicine, Michigan State University, Grand Rapids, MI, USA.

Tau is a microtubule-associated protein that is involved in both normal and pathological processes in neurons. Since the discovery and characterization of tau over 40 years ago, our understanding of tau's normal functions and toxic roles in neurodegenerative tauopathies has continued to expand. Fast axonal transport is a critical process for maintaining axons and functioning synapses, critical subcellular compartments underlying neuronal connectivity. Signs of fast axonal transport disruption are pervasive in Alzheimer's disease and other tauopathies and various mechanisms have been proposed for regulation of fast axonal transport by tau. Post-translational modifications of tau including phosphorylation at specific sites, FTDP-17 point mutations, and oligomerization, confer upon tau a toxic effect on fast axonal transport. Consistent with the well-established dependence of axons on fast axonal transport, these disease-related modifications are closely associated temporally and spatially with axonal degeneration in the early disease stages. These factors position tau as a potentially critical factor mediating the disruption of fast axonal transport that precedes synaptic dysfunction and axonal degeneration at later disease stages. In this chapter, we review the evidence that tau affects fast axonal transport and examine several potential mechanisms proposed to underlie this toxicity.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D001370 Axonal Transport The directed transport of ORGANELLES and molecules along nerve cell AXONS. Transport can be anterograde (from the cell body) or retrograde (toward the cell body). (Alberts et al., Molecular Biology of the Cell, 3d ed, pG3) Axoplasmic Flow,Axoplasmic Transport,Axoplasmic Streaming,Axonal Transports,Axoplasmic Flows,Axoplasmic Transports,Streaming, Axoplasmic,Transport, Axonal,Transport, Axoplasmic,Transports, Axonal,Transports, Axoplasmic
D016875 tau Proteins Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES). tau Protein,Protein, tau,Proteins, tau
D024801 Tauopathies Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration. Tauopathy

Related Publications

Benjamin Combs, and Rebecca L Mueller, and Gerardo Morfini, and Scott T Brady, and Nicholas M Kanaan
January 2002, Neuromolecular medicine,
Benjamin Combs, and Rebecca L Mueller, and Gerardo Morfini, and Scott T Brady, and Nicholas M Kanaan
January 2012, Progress in molecular biology and translational science,
Benjamin Combs, and Rebecca L Mueller, and Gerardo Morfini, and Scott T Brady, and Nicholas M Kanaan
September 2016, Brain research bulletin,
Benjamin Combs, and Rebecca L Mueller, and Gerardo Morfini, and Scott T Brady, and Nicholas M Kanaan
January 2007, Neurology India,
Benjamin Combs, and Rebecca L Mueller, and Gerardo Morfini, and Scott T Brady, and Nicholas M Kanaan
August 2016, European journal of nuclear medicine and molecular imaging,
Benjamin Combs, and Rebecca L Mueller, and Gerardo Morfini, and Scott T Brady, and Nicholas M Kanaan
January 2013, Journal of Alzheimer's disease : JAD,
Benjamin Combs, and Rebecca L Mueller, and Gerardo Morfini, and Scott T Brady, and Nicholas M Kanaan
September 2013, Neurobiology of aging,
Benjamin Combs, and Rebecca L Mueller, and Gerardo Morfini, and Scott T Brady, and Nicholas M Kanaan
January 2002, Neuromolecular medicine,
Benjamin Combs, and Rebecca L Mueller, and Gerardo Morfini, and Scott T Brady, and Nicholas M Kanaan
January 2023, BioFactors (Oxford, England),
Benjamin Combs, and Rebecca L Mueller, and Gerardo Morfini, and Scott T Brady, and Nicholas M Kanaan
July 2014, Mathematical biosciences,
Copied contents to your clipboard!